Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr 27;3(5):1296-1303.
doi: 10.3390/ph3051296.

The Treatment of Melioidosis

Affiliations
Review

The Treatment of Melioidosis

Timothy J J Inglis. Pharmaceuticals (Basel). .

Abstract

Melioidosis is a complex bacterial infection, treatment of which combines the urgency of treating rapidly fatal Gram negative septicaemia with the need for eradication of long-term persistent disease in pulmonary, soft tissue, skeletal and other organ systems. Incremental improvements in treatment have been made as a result of multicentre collaboration across the main endemic region of Southeast Asia and northern Australia. There is an emerging consensus on the three main patterns of antimicrobial chemotherapy; initial (Phase 1) treatment, subsequent eradication (Phase 2) therapy and most recently post-exposure (Phase 0) prophylaxis. The combination of agents used, duration of therapy and need for adjunct modalities depends on the type, severity and antimicrobial susceptibility of infection. New antibiotic and adjunct therapies are at an investigational stage but on currently available data are unlikely to make a significant impact on this potentially fatal infection.

Keywords: adjunct therapy; antibiotics; melioidosis; treatment.

PubMed Disclaimer

References

    1. Wuthiekanun V., Peacock S.J. Management of melioidosis. Exp. Rev. Anti-Infect. Ther. 2006;4:445–455. doi: 10.1586/14787210.4.3.445. - DOI - PubMed
    1. Inglis T.J., Rolim D.B., Rodriguez J.L. Clinical guideline for diagnosis and management of melioidosis. Rev. Inst. Med. Trop. São Paulo. 2006;48:1–4. doi: 10.1590/S0036-46652006000100001. - DOI - PubMed
    1. Cheng A.C., Currie B.J. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 2005;18:383–416. doi: 10.1128/CMR.18.2.383-416.2005. Erratum in: Clin. Microbiol. Rev. 2007, 20: 533. - DOI - PMC - PubMed
    1. Ulett G.C., Hirst R., Bowden B., Powell K., Norton R. A comparison of antibiotic regimens in the treatment of acute melioidosis in a mouse model. J. Antimicrob. Chemother. 2003;51:77–81. - PubMed
    1. Simpson A.J., Suputtamongkol Y., Smith M.D., Angus B.J., Rajanuwong A., Wuthiekanun V., Howe P.A., Walsh A.L., Chaowagul W., White N.J. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin. Infect. Dis. 1999;29:381–387. - PubMed

LinkOut - more resources